Understanding Nanotechnology in the Treatment of Oral Cancer: A Comprehensive Review

被引:11
作者
Taneja, Neeraj [1 ]
Alam, Aftab [2 ]
Patnaik, Ranjana S. [3 ]
Taneja, Tannu [4 ]
Gupta, Sonia [4 ]
Sunil, M. K. [5 ]
机构
[1] Galgotias Univ, Sch Biol & Biomed Sci, Greater Noida, India
[2] Galgotias Univ, Dept Pharmaceut, Greater Noida, India
[3] Galgotias Univ, Sch Biol & Biomed Sci, Greater Noida, India
[4] Sri Sukhmani Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Dera Bassi, Mohali, India
[5] Teerthanker Mahaveer Dent Coll & Hosp, Dept Oral Med & Radiol, Moradabad, Uttar Pradesh, India
来源
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2021年 / 38卷 / 06期
关键词
oral cancer; nanotechnology; nanoparticles; organic nanoparticles; inorganic nanoparticles; targeted drug delivery; SQUAMOUS-CELL CARCINOMA; MESOPOROUS SILICA NANOPARTICLES; NANOSTRUCTURED LIPID CARRIERS; SURFACE-PLASMON RESONANCE; DRUG-DELIVERY-SYSTEM; ON-A-CHIP; IN-VIVO; CARBON NANOTUBES; THERAPEUTIC-EFFICACY; LOADED-NANOPARTICLES;
D O I
10.1615/CritRevTherDrugCarrierSyst.2021036437
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oral cancer is the 11th most common cancer in the world with a high morbidity rate. Various conventional therapies have been used for the treatment of oral cancer such as surgery, radiotherapy, and chemotherapy used either alone or in combination but these have many limitations, making them unsuitable for treating oral cancer. Nanotechnology has been emerged out as an innovative tool in the field of oral cancer which has proved to provide effective results overcoming the limitations of conventional drug therapies. This system involves a nanoparticle drug delivery system based on a targeted therapy in which therapeutic drugs or agents act on the targeted cells without affecting normal healthy cells. Literature has shown that several nanoparticles, organic and inorganic nanoparticles, have been used as the drug delivery system in different types of oral cancers such as oral squamous cell carcinoma, cancer of the tongue, head, and neck cancers. Drugs like cisplatin, 5-fluorouracil, methotrexate, doxorubicin, etc., when coated with nano-polymers have shown better results compared with conventional drugs in oral cancer. Other nanoparticles such as liposomes, hydrogels, nanodiamonds, carbon rods, etc. have also been used with minimal side effects. This paper aims to review and discuss various nanotechnology systems in the field of oral cancer and to evaluate the efficacy of these systems in treating oral cancer compared with conventional drug delivery methods.
引用
收藏
页码:1 / 48
页数:48
相关论文
共 147 条
[1]   Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo [J].
Abbasi, Mehran Mesgari ;
Jahanban-Esfahlan, Rana ;
Monfaredan, Amir ;
Seidi, Khaled ;
Hamishehkar, Hamed ;
Khiavi, Monir Moradzadeh .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) :10705-10711
[2]   A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis [J].
Abolmaali, Samira Sadat ;
Tamaddon, Ali Mohammad ;
Dinarvand, Rassoul .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) :1115-1130
[3]  
Allen TM, 1993, DRUG DELIV, V1, P55, DOI DOI 10.3109/10717549309031342
[4]   Nanoparticles in the clinic [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (01) :10-29
[5]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[6]   Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB) [J].
Arulmozhi, V. ;
Pandian, K. ;
Mirunalini, S. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 110 :313-320
[7]  
Asar SL, 2019, ALEX DENT J, V44, P17, DOI DOI 10.21608/ADJALEXU.2019.57569
[8]   Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment [J].
Ashfaq, Usman Ali ;
Riaz, Muhammad ;
Yasmeen, Erum ;
Yousaf, Muhammad Zubair .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2017, 34 (04) :317-353
[9]   Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics [J].
Ashrafizadeh, Milad ;
Ahmadi, Zahra ;
Mohamadi, Neda ;
Zarrabi, Ali ;
Abasi, Sara ;
Dehghannoudeh, Gholamreza ;
Tamaddondoust, Rosette N. ;
Khanbabaei, Hashem ;
Mohammadinejad, Reza ;
Thakur, Vijay Kumar .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 145 :282-300
[10]   Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation [J].
Astolfi, Laura ;
Ghiselli, Sara ;
Guaran, Valeria ;
Chicca, Milvia ;
Simoni, Edi ;
Olivetto, Elena ;
Lelli, Giorgio ;
Martini, Alessandro .
ONCOLOGY REPORTS, 2013, 29 (04) :1285-1292